600211 西藏藥業
按盤價 
39.180 -0.490 (-1.235%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 7.760 | 24.311 | 28.952 | 25.200 | 13.110 |
| 總資產報酬率 ROA (%) | 4.719 | 17.031 | 22.524 | 18.439 | 9.360 |
| 投入資產回報率 ROIC (%) | 5.692 | 20.255 | 26.100 | 21.711 | 11.028 | 邊際利潤分析 |
| 銷售毛利率 (%) | 92.899 | 94.215 | 94.218 | 95.052 | 94.258 |
| 營業利潤率 (%) | 43.715 | 35.010 | 41.346 | 28.685 | 18.189 |
| 息稅前利潤/營業總收入 (%) | 42.732 | 32.585 | 39.366 | 27.581 | 18.307 |
| 淨利潤/營業總收入 (%) | 39.090 | 30.755 | 37.662 | 25.851 | 14.691 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 69.753 | 95.405 | 81.680 | 119.799 | 160.019 |
| 價值變動淨收益/利潤總額(%) | -0.220 | 0.879 | -0.337 | -18.937 | -1.541 |
| 營業外收支淨額/利潤總額(%) | 0.107 | -0.309 | -0.726 | -0.100 | -0.272 | 償債能力分析 |
| 流動比率 (X) | 2.884 | 2.827 | 4.657 | 2.873 | 2.643 |
| 速動比率 (X) | 2.768 | 2.717 | 4.482 | 2.779 | 2.545 |
| 資產負債率 (%) | 33.857 | 33.984 | 16.751 | 26.458 | 26.072 |
| 帶息債務/全部投入資本 (%) | 19.141 | 15.323 | 5.972 | 12.565 | 13.210 |
| 股東權益/帶息債務 (%) | 375.161 | 489.514 | 1,563.149 | 689.815 | 647.811 |
| 股東權益/負債合計 (%) | 180.217 | 178.338 | 492.663 | 275.561 | 281.766 |
| 利息保障倍數 (X) | -41.484 | -14.064 | -23.418 | -25.643 | 108.986 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 72.152 | 73.724 | 75.536 | 63.038 | 64.691 |
| 存貨周轉天數 (天) | 328.093 | 329.216 | 272.415 | 245.342 | 291.134 |
| 備註： | 即時報價更新時間為 25/05/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
